Other Information
+Added: Adoption, Modification and Termination of Rule 10b5-1 Plans and Certain Other Trading Arrangements.
+Added: On August 17, 2023 , Maxine Gowen , a member of our Board of Directors , adopted a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule10b5-1(c)(1) under the Exchange Act.
+Added: Sales may commence under the plan on November 16, 2023 and the plan terminates on December 31, 2024 , subject to earlier termination in accordance with its terms.
+Added: The aggregate number of securities to be sold under the plan is 44,801 shares of common stock.
Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
001-37581), filed with the SEC on October 13, 2015).
−Removed: Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Registrant.
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.2 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37581), filed with the SEC on August 7, 2023).
Amended and Restated Bylaws of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
001-37581), filed with the SEC on June 24, 2020).
−Removed: Office Lease, dated May 26, 2023, by and between the Registrant and CBCC – Lee Road Acquisitions, LLC (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on June 1, 2023).
−Removed: Amended and Restated Employment Agreement, effective as of July 1, 2023, by and between the Registrant and Joseph Monahan (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on June 12, 2023).
Certification of Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act.
11 unchanged sentences
Section 1350, and are not being filed for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
−Removed: Pursuant to Item 601(a)(5) of Regulation S-K promulgated by the SEC, certain exhibits and schedules to this agreement have been omitted.
−Removed: The Company hereby agrees to furnish supplementally to the SEC, upon its request, any or all of such omitted exhibits or schedules.
−Removed: Indicates management contract or compensatory plan.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ACLARIS THERAPEUTICS, INC.
−Removed: August 7, 2023
+Added: November 6, 2023
/s/ Douglas Manion
2 unchanged sentences
(On behalf of the Registrant)
−Removed: August 7, 2023
+Added: November 6, 2023
/s/ Kevin Balthaser
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.